MOH — authorised 1 July 2009
- Marketing authorisation holder: SANOFI AVENTIS US
- Status: likely_approved
🇮🇱 Multaq in Israel
MOH authorised Multaq on 1 July 2009
Marketing authorisation
Multaq in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in Israel
Frequently asked questions
Is Multaq approved in Israel?
Yes. MOH authorised it on 1 July 2009.
Who is the marketing authorisation holder for Multaq in Israel?
SANOFI AVENTIS US holds the Israeli marketing authorisation.